Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: A study to determine feasibility and reproducibility in the context of clinical care

Breast Cancer Research and Treatment

Volumn 118, Issue 3, 2009, Pages 635-643

  Tebbit, Christopher L ^a   Zhai, Jun ^b   Untch, Brian R ^a   Ellis, Matthew J ^c   Dressman, Holly K ^b   Bentley, Rex C ^a   Baker, Jay A ^a   Marcom, Paul K ^d   Nevins, Joseph R ^b   Marks, Jeffrey R ^a   Olson Jr , John A ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Genomic testing; Genomics; Tissue aquisition

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NEEDLE BIOPSY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FROZEN SECTIONS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TUMOR MARKERS, BIOLOGICAL;

EID: 70449569064     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0301-1     Document Type: Article

References (26)

1. M West C Blanchette H Dressman, et al. 2001 Predicting the clinical status of human breast cancer by using gene expression profiles Proc Natl Acad Sci USA 98 11462 11467 10.1073/pnas.201162998 10.1073/pnas.201162998 1:CAS:528:DC%2BD3MXnt1yqu7w%3D 11562467 (Pubitemid 32928751)
2. MJ van de Vijver YD He LJ van't Veer, et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009 10.1056/NEJMoa021967 10.1056/NEJMoa021967 12490681 (Pubitemid 35461656)
3. LJ van't Veer H Dai MJ van de Vijver, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 2002 415 530 536 10.1038/415530a 10.1038/415530a (Pubitemid 34130608)
4. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 10.1038/35021093 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D 10963602 (Pubitemid 30671230)
5. T Sorlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 10.1073/pnas.191367098 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D 11553815 (Pubitemid 32878711)
6. C Fan DS Oh L Wessels, et al. 2006 Concordance among gene-expression- based predictors for breast cancer N Engl J Med 355 560 569 10.1056/NEJMoa052933 10.1056/NEJMoa052933 1:CAS:528:DC%2BD28XotVKnur4%3D 16899776 (Pubitemid 44200649)
7. TA Buchholz DN Stivers J Stec, et al. 2002 Global gene expression changes during neoadjuvant chemotherapy for human breast cancer Cancer J 8 461 468 10.1097/00130404-200211000-00010 10.1097/00130404-200211000-00010 12500855
8. L Pusztai M Ayers J Stec, et al. 2003 Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors Clin Cancer Res 9 2406 2415 1:CAS:528:DC%2BD3sXlt1ykurw%3D 12855612
9. R Rouzier CM Perou WF Symmans, et al. 2005 Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 5678 5685 10.1158/1078-0432.CCR-04-2421 10.1158/1078-0432.CCR-04-2421 1:CAS:528:DC%2BD2MXos1Cjs7k%3D 16115903 (Pubitemid 41170290)
10. E Huang SH Cheng H Dressman, et al. 2003 Gene expression predictors of breast cancer outcomes Lancet 361 1590 1596 10.1016/S0140-6736(03)13308-9 10.1016/S0140-6736(03)13308-9 1:CAS:528:DC%2BD3sXjs1Wltbo%3D 12747878 (Pubitemid 36578995)
11. J Pittman E Huang H Dressman, et al. 2004 Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes Proc Natl Acad Sci USA 101 8431 8436 10.1073/pnas.0401736101 10.1073/pnas.0401736101 1:CAS:528:DC%2BD2cXkvFOmtr4%3D 15152076 (Pubitemid 38736592)
12. E Huang S Ishida J Pittman, et al. 2003 Gene expression phenotypic models that predict the activity of oncogenic pathways Nat Genet 34 226 230 10.1038/ng1167 10.1038/ng1167 1:CAS:528:DC%2BD3sXktFSlt7c%3D 12754511 (Pubitemid 36666937)
13. AH Bild G Yao JT Chang, et al. 2006 Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature 439 353 357 10.1038/nature04296 10.1038/nature04296 1:CAS:528:DC%2BD28XkvF2mtg%3D%3D 16273092 (Pubitemid 43128862)
14. C Sotiriou MJ Piccart 2007 Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7 545 553 10.1038/nrc2173 10.1038/nrc2173 1:CAS:528:DC%2BD2sXmvVakurc%3D 17585334 (Pubitemid 46985399)
15. HK Dressman A Berchuck G Chan, et al. 2007 An integrated genomic-based approach to personalized treatment of patients with advanced-stage ovarian cancer J Clin Oncol 25 517 525 10.1200/JCO.2006.06.3743 10.1200/JCO.2006.06.3743 1:CAS:528:DC%2BD2sXivF2mtLw%3D 17290060 (Pubitemid 350002958)
16. Y Gong K Yan F Lin, et al. 2007 Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study Lancet Oncol 8 203 211 10.1016/S1470-2045(07)70042-6 10.1016/S1470-2045(07) 70042-6 1:CAS:528:DC%2BD2sXisVCqsrY%3D 17329190 (Pubitemid 46304454)
17. DL Manning RA McClelland JM Knowlden, et al. 1995 Differential expression of oestrogen regulated genes in breast cancer Acta Oncol 34 641 646 10.3109/02841869509094041 10.3109/02841869509094041 1:STN:280: DyaK28%2Fgsleksw%3D%3D 7546832
18. DL Manning RA McClelland JM Gee, et al. 1993 The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer Eur J Cancer 29 1462 1468 10.1016/0959-8049(93)90021-7 10.1016/0959-8049(93)90021-7
19. S Deb C Tessier A Prigent-Tessier, et al. 1999 The expression of interleukin-6 (IL-6), IL-6 receptor, and gp 130 kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17beta-estradiol and prolactin Endocrinology 140 4442 4450 10.1210/en.140.10.4442 10.1210/en.140.10.4442 1:CAS:528:DyaK1MXmtFGru74%3D 10499497
20. L Altucci R Addeo L Cicatiello, et al. 1996 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells Oncogene 12 2315 2324 1:CAS:528:DyaK28XjvFCmtL4%3D 8649771
21. A Derrien KM Druey 2001 RGS16 function is regulated by epidermal growth factor receptor-mediated tyrosine phosphorylation J Biol Chem 276 48532 48538 1:CAS:528:DC%2BD38XltFaj 11602604
22. M Isomura K Okui T Fujiwara S Shin Y Nakamura 1996 Isolation and mapping of RAB2L, a human cDNA that encodes a protein homologous to RalGDS Cytogenet Cell Genet 74 263 265 10.1159/000134431 10.1159/000134431 1:CAS:528: DyaK2sXjtVaqtg%3D%3D 8976381
23. W Xia JS Chen X Zhou, et al. 2004 Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients Clin Cancer Res 10 3815 3824 10.1158/1078-0432.CCR-03-0527 10.1158/1078-0432.CCR-03-0527 1:CAS:528:DC%2BD2cXksVKnt70%3D 15173090 (Pubitemid 38697617)
24. H Zhang JK Kim CA Edwards Z Xu R Taichman CY Wang 2005 Clusterin inhibits apoptosis by interacting with activated bax Nat Cell Biol 7 909 915 10.1038/ncb1291 10.1038/ncb1291 1:CAS:528:DC%2BD2MXpslaksb0%3D 16113678 (Pubitemid 41486292)
25. B Wood R Junckerstorff G Sterrett F Frost J Harvey P Robbins 2007 A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions Pathology 39 391 395 10.1080/00313020701444465 10.1080/00313020701444465 1:CAS:528:DC%2BD2sXosFarsr8%3D 17676479 (Pubitemid 47221462)
26. GB Mann VD Fahey F Feleppa MR Buchanan 2005 Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer J Clin Oncol 23 5148 5154 10.1200/JCO.2005.02.076 10.1200/JCO.2005.02.076 16051956 (Pubitemid 46224023)